Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,578,251
-$1,695,487 QoQ
Shares Held
113,568
-18.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#501
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dai-ichi Life Insurance Company, Ltd holds $212,153,650 across 9 Drug Manufacturers - General names. ABBV ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,768 | $57,294,377 | |
| 2 | JNJ |
Johnson & Johnson
|
174,058 | $44,205,510 | |
| 3 | MRK |
Merck & Co., Inc.
|
274,795 | $35,311,157 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
113,568 | $28,578,251 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
183,684 | $23,206,636 | |
| 6 | AMGN |
Amgen Inc
|
34,660 | $12,551,079 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
99,653 | $5,742,005 | |
| 8 | PFE |
Pfizer Inc
|
170,206 | $4,098,560 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,578,251 | 113,568 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $30,273,738 | 139,196 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $36,135,465 | 158,149 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $30,566,058 | 132,012 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $27,959,754 | 150,629 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $35,089,152 | 167,474 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,003,633 | 140,707 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,822,167 | 140,886 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,197,450 | 152,737 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $27,656,983 | 151,878 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $26,778,816 | 172,800 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $25,829,862 | 173,285 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $52,725,911 | 391,345 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,347,152 | 115,123 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,637,877 | 121,514 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,966,426 | 118,966 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,319,620 | 119,611 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,842,305 | 91,557 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,379,351 | 91,428 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,935,474 | 92,106 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $13,179,781 | 117,008 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $60,158,199 | 555,888 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $68,110,433 | 635,655 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,532,362 | 131,663 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,962,312 | 132,026 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $8,075,149 | 105,987 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||